Hospital pharmacist on the ward: how to discuss a possible discrepancy in a prescription with a doctor

When a discrepancy is noticed

When a hospital pharmacist notices a possible discrepancy in a prescription, they first gather what can be checked: the medication name, dose, patient details, and source of the concern. They establish whether the question concerns the dose, route of administration, or an interaction, and assess its urgency before contacting the doctor. In the conversation, it helps to separate observation from conclusion: the prescription raises a concern, but that does not yet mean the order is wrong. This gives the doctor a specific point to verify rather than a challenge to their decision. If the medication is due to be given soon, assessing urgency beforehand makes it possible to say clearly when a decision is needed. A concern prepared this way keeps both people focused on patient safety.

How to make contact

It is best to start with the details in the prescription and ask about the intended plan, rather than assess the competence of the person who wrote it. The pharmacist might say, “I see this dose alongside these patient details. Does it take the patient’s kidney function into account?” If the matter is urgent, they should also explain why a decision is needed before the medication is given. Asking the question alone is not enough, however, if the person contacted cannot change the order. It is therefore worth establishing who is authorized to resolve the concern and asking that person to confirm the regimen. This approach leaves room for the doctor to explain their intention without losing sight of the specific issue that determines what happens next.

Differences in professional status

Differences in professional status can make it harder for a pharmacist to ask again, especially when the first message goes unanswered. A review of 294 publications on speaking up in healthcare frames the concept around conveying a concern to someone able to act; it does not test the effectiveness of the conversational approach described here. For a ward, this raises a practical question: did the urgent message reach someone who can make a decision, and what should happen if they do not respond? A manager can establish a route for following up, so that the relative positions of the people involved do not bring the matter to a silent end. A courteous tone helps the conversation, but it does not, by itself, confirm that the medication regimen is appropriate or replace a clinical decision.

What pharmacists say

In a qualitative study, 13 community pharmacists described barriers to their involvement in medication safety and their experiences of collaboration. These are the views of a small group working outside hospitals, not a measure of how often such problems occur on wards. The study also does not establish that every interaction reported by participants was clinically significant. Their experiences can, however, prompt a team to examine its own practice: what makes it difficult for a pharmacist to contact a doctor about a prescription concern, and is it clear whom to approach? The answers need to be sought locally, without automatically transferring the findings. That way, discussing barriers helps the team understand how its ward works rather than attributing to it problems observed elsewhere.

The clinical response

After receiving the message, the doctor should acknowledge the concern, then communicate a decision or say when they will review the order. They may change it, maintain it after review, or request more information; in each case, the pharmacist needs to know the outcome. If they assess the situation differently, it helps to state the information on which the decision rests rather than end the conversation with reassurance alone. If an urgent concern remains unresolved, patient safety must be protected while it is clarified, in line with local procedures. Acknowledging receipt is not yet a clinical answer, but it establishes who is handling the question and when to follow up for a decision.

Recording the decision

Once a decision has been made, the pharmacist’s concern, the doctor’s explanation, and the next steps should be recorded through the appropriate channels. If the order has changed, the record should identify the change and who is responsible for informing the person who will carry it out. The pharmacist needs confirmation that the question has been resolved, and the next shift should be able to see how the final version of the order was reached. Closing the communication loop reduces repeat calls prompted by the same uncertainty. A prescription being amended must not be confused with a determination that the earlier entry was definitely an error. Documentation should convey the decision and its rationale, not hastily assign blame.

Learning from recurring questions

If similar prescriptions regularly prompt the same questions, one conversation is not enough. The team can group concerns by where they arise and check whether the ambiguity stems from a form, a standard dose, or how different professions communicate. It is also worth agreeing which questions require urgent escalation, so pharmacists and doctors understand the significance of a concern in the same way. The team should separately check whether pharmacists receive confirmation of decisions and feedback after raising concerns. This approach helps identify recurring difficulties in how work is organized, rather than treating every concern as a dispute between two people. Findings from local reports still need to be checked before the team changes its current way of working.

Specific facts, a clear request for a decision, and confirmation of the response help structure conversations between hospital pharmacists and doctors on the ward.

Empatyzer in conversations between hospital pharmacists and doctors

Before speaking with a doctor, a hospital pharmacist can ask Em for help structuring three parts of the message: what they noticed in the prescription, why the matter is urgent, and what decision they need. They can then check that the brief question includes the patient details needed for verification and asks for an answer rather than judging the doctor. Comparing colleagues’ communication preferences may help them choose the tone of the question without changing its clinical content. In team mode, Em can help develop a shared rule for acknowledging urgent messages: who responds, when a message should be sent again, and how the pharmacist learns the decision. Micro-lessons can reinforce this brief conversation structure. This supports preparation for the conversation and agreement on how to work together; it does not assess whether a prescription is correct or replace the doctor’s decision or local procedures.